COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 659: Articles 6581-6590  | Next

Assessment of COVID-19 hospitalization risk during SARS-CoV-2 Omicron relative to Delta variant predominance, New York City, August 2021-January 2022
Greene, S. K., Levin-Rector, A. K., Luoma, E., Amin, H., McGibbon, E., Mathes, R. W., Ahuja, S. D.
10.1101/2022.07.15.22276814 — Posted: 2022-07-17
From The Plague Horrors of Cholera, What Partnership Lessons Can Be Learnt in Addressing COVID-19 In Zambia
CHOTA, P., Matenga, T. F. L., Zulu, J. M., Mweemba, O.
10.1101/2022.07.15.22277666 — Posted: 2022-07-17
Urban birds' flight responses were unaffected by the COVID-19 shutdowns
Mikula, P., Bulla, M., Blumstein, D., Benedetti, Y., Floigl, K., Jokimaki, J., Kaisanlahti-Jokimaki, M.-L., Marko, G., Morelli, F., Moller, A. P., Siretckaia, A., Szakony, S., Weston, M., Zeid, F. A., Tryjanowski, P., Albrecht, T.
10.1101/2022.07.15.500232 — Posted: 2022-07-16
Lasting alterations in monocyte and dendritic cell subsets in individuals after hospitalization for COVID-19
Hopkins, F. R., Govender, M., Svanberg, C., Nordgren, J., Waller, H., Nilsdotter-Augustinsson, A., Henningsson, A. J., Hagbom, M., Sjowall, J., Nystrom, S., Larsson, M.
10.1101/2022.07.15.500185 — Posted: 2022-07-15
Pangenome analysis of SARS-CoV2 strains to Identify Potential vaccine targets by Reverse Vaccinology
Tariq, M. H., Amir, A., Irshad, H.
10.1101/2022.07.15.500170 — Posted: 2022-07-15
Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2
Ragonnet-Cronin, M., Nutalai, R., Huo, J., Dijokaite-Guraliuc, A., Das, R., Tuekprakhon, A., Supasa, P., Liu, C., Selvaraj, M., Groves, N., Hartman, H., Ellaby, N., Sutton, J. M., Bahar, M. W., Zhou, D., Fry, E., Ren, J., Brown, C., Klenerman, P., Dunachie, S. J., Mongkolsapaya, J., Hopkins, S., Chand, M., Stuart, D. I., Screaton, G. R., Rokadiya, S.
10.1101/2022.07.14.500063 — Posted: 2022-07-15
Neutralization sensitivity of Omicron BA.2.75 to therapeutic monoclonal antibodies
Yamasoba, D., Kimura, I., Kosugi, Y., Uriu, K., Fujita, S., Ito, J., Sato, K., The Genotype to Phenotype Japan (G2P-Japan) Consortium
10.1101/2022.07.14.500041 — Posted: 2022-07-15
Vitamin C is an efficient natural product for prevention of SARS-CoV-2 infection by targeting ACE2 in both cell and in vivo mouse models
Zuo, Y., Zheng, Z., Huang, Y., He, J., Zang, L., Ren, T., Cao, X., Miao, Y., Yuan, Y., Liu, Y., Ma, F., Tian, S., Dai, J., Ding, Q., Zheng, H.
10.1101/2022.07.14.499651 — Posted: 2022-07-15
A zebrafish model of COVID-19-associated cytokine storm syndrome reveals that the Spike protein signals via TLR2
Tyrkalska, S. D., Martinez-Lopez, A., Pedoto, A., Candel, S., Cayuela, M. L., Mulero, V.
10.1101/2022.07.14.500031 — Posted: 2022-07-15
Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine
Leekha, A., Saeedi, A., Sefat, S. R., Kumar, M., Paniagua, M. M., Damian, A., Kulkarni, R., Rezvan, A., Mosoumi, S., Liu, X., Cooper, L. J. N., Sebastian, M., Hurst, B. L., Varadarajan, N.
10.1101/2022.07.14.500068 — Posted: 2022-07-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).